Antidepressant-like activity of the endogenous amine, 1-methyl-1,2,3,4- tetrahydroisoquinoline in the behavioral despair test in the rat, and its neurochemical correlates: A comparison with the classical antidepressant, imipramine

European Journal of Pharmacology

Volumn 700, Issue 1-3, 2013, Pages 110-117

  Wa̧sik, Agnieszka ^a   Mozdzeń, Edyta ^a   Romańska, Irena ^a   Michaluk, Jerzy ^a   Antkiewicz Michaluk, Lucyna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

1 Methyl 1,2,3,4 tetrahydroisoquinoline; Depression; Forced swimming test; Imipramine; Metabolism of monoamines; Rat

Indexed keywords

1 METHYL 1,2,3,4 TETRAHYDROISOQUINOLINE; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; ANTIDEPRESSANT AGENT; DOPAMINE; IMIPRAMINE; MONOAMINE; NORADRENALIN; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIORAL DESPAIR TEST; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOSE RESPONSE; FORCED SWIMMING TEST; LOCOMOTION; MALE; MONOAMINE METABOLISM; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; OXIDATION; PRIORITY JOURNAL; RAT; SEROTONIN METABOLISM; SUBSTANTIA NIGRA;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIPRAMINE; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SWIMMING; TETRAHYDROISOQUINOLINES;

EID: 84872906805     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.11.063     Document Type: Article

References (46)

1. J.C. Alvarez, M. Sanceaume, C. Advenier, and O. Spreux-Varoquaux Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice Eur. Neuropsychopharmacol 10 1999 31 36
2. J.D. Amsterdam, A.B. Newberg, I. Soeller, and J. Shults Greater striatal dopamine transporter density may be associated with major depressive episode J. Affect. Disord. 141 2012 425 431
3. L. Antkiewicz-Michaluk, M. Filip, J. Michaluk, I. Romańska, E. Przegaliński, and J. Vetulani An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats J. Neural Transm. 114 2007 307 317 (Pubitemid 46328651)
4. L. Antkiewicz-Michaluk, J.W. Łazarewicz, A. Patsenka, M. Kajta, E. Ziemińska, E. Salińska, A. Wa̧sik, K. Gołembiowska, and J. Vetulani The mechanism of 1,2,3,4-tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate-induced excitotoxicity J. Neurochem. 97 2006 846 856
5. L. Antkiewicz-Michaluk, J. Michaluk, M. Mokrosz, I. Romańska, E. Lorenc-Koci, S. Otha, and J. Vetulani Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties J. Neurochem. 78 2001 100 108 (Pubitemid 32622592)
6. T.C. Baghai, H.P. Volz, and H.J. Moller Drug treatment of depression in the 2000s: an overview of achievements in the last 10 years and future possibilities World J. Bioch. Psychiatry 7 2006 198 222 (Pubitemid 44650530)
7. H.M.T. Barros, and M. Ferigolo Ethopharmacology of imipramine in the forced-swimming test: gender differences Neurosci. Biobehav. Rev. 23 1998 279 286 (Pubitemid 29011630)
8. U. Bonnet Moclobemide: therapeutic use and clinical studies CNS Drug Rev. 9 2003 97 140 (Pubitemid 36438138)
9. C.E. Byrum, E.P. Ahearn, and K.R. Krishnan A neuroanatomic model for depression. Prog. Neuropsychopharmacol Biol. Psych. 23 1999 175 193 (Pubitemid 29156839)
10. S. Campbell, and G. MacQueen An update on regional brain volume differences associated with mood disorders Curr. Opin. Psychiatry 19 2006 25 33 (Pubitemid 44406141)
11. J.F. Cryan, and I. Lucki Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C) receptors J. Pharmacol. Exp. Ther. 295 2000 1120 1126
12. J.F. Cryan, A. Markou, and I. Lucki Assessing antidepressant activity in rodents: recent development and future Leeds Trends. Pharmacol. Sci. 23 2002 238 245 (Pubitemid 34465544)
13. J.F. Cryan, M.E. Page, and I. Lucki Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment Psychopharmacology 182 2005 335 344 (Pubitemid 41464645)
14. M.J. Detke, M. Rickels, and I. Lucki Active behaviors in the rat forced swimming test differentially produced by serotoninergic and noradrenergic antidepressants Psychopharmacology (Berlin) 121 1995 66 72
15. R.S. Duman Pathophysiology of depression: the concept of synaptic plasticity Eur. Psychiatry 17 2002 306 310 (Pubitemid 34839393)
16. J.A. Dykens Free radicals and mitochondria dysfunction in excitotoxicity and neurodegenerative disease. In: Cell Death and Diseases of the Nervous System 1999 Humana Press Totowa pp., 45-68
17. M. Ferigolo, H.M.T. Barros, A.R. Marquardt, and M. Tannhauser Comparison of behavioral effects of moclobemide and deprenyl during forced swimming Pharmacol. Biochem. Behav. 60 1998 431 437 (Pubitemid 28282684)
18. M. Filip, L. Antkiewicz-Michaluk, M. Zaniewska, M. Frankowska, A. Gołda, J. Vetulani, and E. Przegaliński Effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline on the behavioral effects of cocaine in rats J. Physiol. Pharmacol. 58 2007 625 639
19. I. Goshen, T. Kreisel, O. Ben-Menachem-Zidon, T. Licht, J. Weidenfeld, T. Ben-Hur, and R. Yirmyia Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression Mol. Psychiatry 13 2008 717 728 (Pubitemid 351861529)
20. G.L. Grunewald, T.J. Reitz, J.A. Ruth, S. Vollmer, L.E. Eiden, and C.O. Rutledge Inhibition of neuronal uptake of 3H-biogenic amines into rat cerebral cortex by partially and fully saturated derivatives of imipramine and desipramine. The importance of the aromatic ring in adrenergic amines - part 3 Biochem. Pharmacol. 28 1979 417 421
21. W. Haefely, W.P. Burkard, A.M. Cesura, R. Kettler, H.P. Lorez, J.R. Martin, J.G. Richards, R. Scherschlicht, and M. Da Prada Biochemistry and pharmacology of moclobemide, a prototype RIMA Psychopharmacology (Berlin) 106 1992 6 14
22. J.I. Javaid, J.M. Pere,l, and J.M. Davis Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain Life Sci. 24 1979 21 28 (Pubitemid 9107782)
23. K. Kikuchi, Y. Nagatsu, Y. Makino, T. Mashino, S. Ohta, and M. Hirobe Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds 1,2,3,4-tetrahydroisoquinoline and 1-methyl-1,2,3,4- tetrahydroisoquinoline Drug Metab. Dispos. 19 1991 257 262
24. Y. Kitamura, K. Kitagawa, S. Kimoto, H. Sagara, K. Shibata, H. Kawasaki, T. Sendo, and Y. Gomita Selegilin exerts antidepressant-like effects during the forced swim test in adrenocorticotropic hormone-treated rats J. Pharmacol. Sci. 106 2008 639 644 (Pubitemid 351556243)
25. M. Maes, I. Mihaylova, M. Kubera, and J.C. Leunis An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitorsative stress is another factor underpinning the comorbidity between major depression and CFS Neuro Endocrinol Lett. 29 2008 313 319
26. M. Maes, R. Yirmyia, J. Noraberg, S. Brene, J. Hibbeln, G. Perini, M. Kubera, P. Bob, B. Lerer, and M. Maj The inflammatory and neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression Metab. Brain Dis. 24 2009 27 53
27. J. Maj, and Z. Rogóż Synergistic effects of amantadine and imipramine in the forced swimming test Pol. J. Pharmacol 52 2000 111 114 (Pubitemid 30311781)
28. J.J. Mann, and S. Kapur A dopaminergic hypothesis of major depression Clin. Neuropharmacol. 18 1995 57 65
29. J. Michaluk, A. Krygowska-Wajs, B. Karolewicz, and L. Antkiewicz-Michaluk Role of noradrenergic system In the mechanism of action of endogenous neurotoxin 1,2,3,4-tetrahydroisoquinoline: biochemical and functional studies Pol. J. Pharmacol. 54 2002 19 25 (Pubitemid 34269619)
30. H. Miura, M. Naoi, D. Nakahara, T. Ohta, and T. Nagatsu Effects of moclobemide on forced-swimming stress and brain monoamine levels In mice Pharmacol. Biochem. Behav. 53 1996 469 475 (Pubitemid 26059209)
31. A.B. Newberg, J.D. Amsterdam, and J. Shults Dopamine transporter density may be associated with the depressed affect in healthy subjects Nucl. Med. Commun. 28 2007 3 6 (Pubitemid 44949681)
32. S.O. Ogren, S.B. Ross, H. Hall, A.C. Holm, and A.L. Renyi The pharmacology of zimelidine: a 5-HT selective reuptake inhibitor Acta Psychiatr. Scand. 290 1981 127 151 (Pubitemid 11156107)
33. A. Patsenka, and L. Antkiewicz-Michaluk Inhibition of rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds - 1,2,3,4-tetrahydro-isoquinoline alkaloids Pol. J. Pharmacol. 56 2004 727 734 (Pubitemid 40287474)
34. A. Patsenka, K. Gołembiowska, E. Ziemińska, E. Salińska, J. Łazarewicz, A. Wa̧sik, J. Michaluk, and L. Antkiewicz-Michaluk Neuroprotective effects of 1-methyl-1,2,3,4- tetrahydroisoquinoline: in vitro and in vivo studies in rats Pol. J. Pharmacol. 56 2004 179 180
35. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Behavioral despair test in rats: a new model sensitive to antidepressant treatments Eur. J. Pharmacol. 47 1978 379 391
36. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioural despair test in mice: a primary screening test for antidepressants Arch. Int. Pharmacodyn 229 1977 327 336 (Pubitemid 8225714)
37. M.A. Rogers, J.L. Bradshaw, C. Pantelis, and J.G. Philips Frontostriatal deficits in unipolar major depression Brain Res. Bull. 47 1998 297 310 (Pubitemid 29042630)
38. G. Scapagnini, S. Davinelli, F. Drago, A. De Lorenzo, and G. Oriani Antioxidants as antidepressants: fact or fiction? CNS Drugs 26 2012 477 490
39. P.J. Shah, A.D. Ogilvie, G.M. Goodwin, and K.P. Ebmeier Clinical and psychometric correlates of dopamine D-2 binding in depression Psychol. Med. 27 1997 1247 1256 (Pubitemid 27494090)
40. C.A. Stockmeier, G.J. Mahajan, L.C. Konick, J.C. Overholser, G.J. Jurjus, and H.Y. Meltzer Cellular changes in the postmortem hippocampus in major depression Biol. Psychiatry 56 2004 640 650 (Pubitemid 39446845)
41. M. Versiani, U. Oggero, P. Alterwain, R. Capponi, F. Dajas, G. Heinze-Martin, C.A. Marquez, M.A. Poleo, L.E. Rivero-Almanzor, and L. Rossel A double-blind comparative trial of moclobemide vs. imipramine and placebo in major depressive episodes Br. J. Psychiatry 6 1989 72 77 (Pubitemid 19282142)
42. J. Vetulani, L. Antkiewicz-Michaluk, I. Nalepa, and M. Sansone A possible physiological role for cerebral tetrahydroisoquinolines Neurotox. Res. 5 2003 147 156
43. J. Vetulani, and I. Nalepa Antidepressants: past, present and future Eur. J. Pharmacol. 405 2000 351 363
44. J. Weiss, and C. Kilts Animal models of depression and schizophrenia C Nemeroff, A. Schatzberg, Textbook of Psychopharmacology 1998 American Psychiatryc Association Press New York 88 123
45. M.B. Youdim, and Y.S. Bakhle Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness Brit. J. Pharmacol. 147 2006 287 296
46. M.B. Youdim, D. Edmondson, and K.F. Tipton The therapeutic potential of monoamine oxidase inhibitors Nat. Rev. Neurosci. 7 2006 295 309